A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi

British Journal of Clinical Practice

Volumn 51, Issue 1, 1997, Pages 8-10

  Halsoub, M D ^a,b   Uwaydah, A K ^a,b   Imatar, M D ^a,b   Zebeib, M ^a,b   Elhag, K M ^a,b  

^a Department Medicine ^*

^b HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; BACTEREMIA; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 0030936686     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Uwaydah AK, Matar I, Chacko KC, Davidson JC. The emergence of antimicrobial resistant Salmonella typhi in Qatar: epidemiology and therapeutic implications. Trans R Soc Trop Med Hyg 1991; 85: 790-792.
2. Rowe B, Ward LR, Threlfall EJ. Spread of multiresistant Salmonella typhi. Lancet 1990; 336: 1065.
3. Wallace M, Yousif AA. Spread of multiresistant Salmonella typhi. Lancet 1990; 336: 1065-1066.
4. Asperilla OM, Smego RA, Jr, Scott LR. Quinolone antibiotics in treatment of Salmonella infections. Rev Infect Dis 1990; 12: 873-889.
5. Bhutta AZ, Naqvi SH, Razzaw RA, Farooqui BJ. Multi drug resistant typhoid in children: presentation and clinical features. Rev Infect Dis 1991 ; 13: 832-836.
6. Chandra R, Srinivasa S, Nalini Pet al. Multi drug resistant enteric fever. J Trop Med Hyg 1992; 95: 284-287.
7. Koul PB, Murali MV, Sharma Aet al. Multi resistant Salmonella typhi infection: clinical profile and therapy. Ind Pediatr 1991; 28: 357-361.
8. Kauffmann-White Scheme. Published by Salmonella Reference Laboratory, PHLS, UK, 1969.
9. Uwaydah AK, Alsoub HA, Matar I. Randomized prospective study comparing ciprofloxacin in two different doses in the treatment of typhoid fever. JAntimicrob Chemother 1992; 30: 707-711.
10. Jesudassan MV, Jacob John T. Multiresistant Salmonella typhi in India. Lancet 1990; 336: 252.
11. Anand AC, Kataria VK, Singh W, Chatterjee SK. Epidemic multiresistant enteric fever in eastern India. Lancet 1990; 335: 352.
12. Huffman SL. Typhoid fever. In: Strickland GT, ed. Hunter's Tropical Medicine. Philadelphia: W.B. Saunders Company. 1991, 7th edn, 344-359.
13. Huffman TA, Ruiz CJ, Counts GWet al. Waterborne typhoid fever in Dade County, Florida: clinical and therapeutic evaluation of 105 bacteremic patients. Am J Med 1975; 59: 481-487.
14. Lasserre R, Sangalang RP, Santiago L. Three day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother 1991; 28: IK-111.
15. Oh HM, Chew SK, Monteiro SH. Multidrug-resistant typhoid in Singapore. Singapore Med J 1994; 35: 599-601.
16. Holmberg SD, Solomon SL, Bloke PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065-1078.
17. Rubens CE, Farrow WE Jr, McGee ZA, Schaffner W. Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic ofnosocomial infections. J Infect Dis 1981; 143: 170-181.
18. Bawdon RE, Craine LR, Patchaudhuri S. Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects. Rev Infect Dis 1982; 4: 1075-1095.
19. Balows A. An overview of recent experiences with plasmid mediated antibiotic resistance or induced virulence in bacterial diseases. J Antimicrob Chemother 1977; 3(SuppI C): 3-6.
20. Peluffo CA, Irino K. Virulence for mice of plasmid bearing epidemic strains of Salmonella typhimurium. In: Levy SB, Clowes RC, Koenig EL, Eds. Molecular Biology, Pathogenicity and Ecology of Bacterial Plasmids. New York: Plenum Press. 1981; 642.